News and Announcements
Charter Hall Acquires 50% Interest in Coles Headquarters Melbourne
- Published September 21, 2016 5:35PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st September 2016, ASX Announcement
Charter Hall Group (ASX:CHC) (Charter Hall or the Group) announces it has entered into an agreement to acquire a 50% tenants-in-common interest in the Melbourne office headquarters of Wesfarmers’ subsidary Coles, a long term occupant of the building which has recently signed a new 15 year lease expiring in 2030.
The purchase was negotiated directly off market from Investa Office Fund (OF), for a total purchase price of $140.5 million. The remaining 50% interest in the property is owned by a private group.
The property, known as the Coles Headquarters, is located at 800 Toorak Road, Hawthorn East, and is 100% leased to the Coles Group Limited for an initial 15 year lease term expiring 17 March 2030, plus options.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
